Log In
Print
BCIQ
Print
Print this Print this
 

alpha galactosidase (PRX-102)

  Manage Alerts
Collapse Summary General Information
Company Protalix BioTherapeutics Inc.
DescriptionPlant cell-expressed recombinant form of human alpha galactosidase A
Molecular Target Alpha galactosidase A
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I/II
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today